Neurosciences

WAIKOLOA, Hawaii — At Hawaiian Eye 2022, Andrew G. Lee, MD, discusses key concepts in diagnosing relative afferent pupillary defects.

Neuroscience specialty pharmaceutical company OWP Pharmaceuticals Inc. has partnered with Eversana, a provider of global services to the life sciences industry, to launch oral liquid formulations for treating neuroscience disorders.

Neuroscience firm Inscopix, Inc. introduced a cloud-based data management system intended to ease collection, organization and sharing of neuroscience research.

In the last year, three therapies were approved by the FDA to significantly reduce relapses of neuromyelitis optica spectrum disorder, a rare autoimmune inflammatory disorder that can leave patients blind or paralyzed.

Before the COVID-19 public health emergency, I was excited about incorporating video visits into my practice. Multiple times a day I had patients who had driven for hours, many of whom had stayed overnight in a region known for expensive accommodations because of lack of access to neuro-ophthalmologists near their home. Others shuttled between the neurosurgery clinic, MRI scanner and my clinic, getting in their car and re-parking, re-registering and waiting multiple times. Everyone faced a multi-hour appointment, shuttling from waiting room to exam room to photography to exam room, before waiting for a physician running late because of providing care to patients with complex disease. The system was broken for patients and this provider.